|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Dreyling, M.; Ghielmini, M.; Rule, S.; Salles, G.; Ladetto, M.; Tonino, S. H.; Herfarth, K.; Seymour, J. F. und Jerkeman, M.
(2021):
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines tor diagnosis, treatment and follow-up.
In: Annals of Oncology, Bd. 32, Nr. 3: S. 298-308
Rule, S.; Jurczak, W.; Jerkeman, M.; Rusconi, C.; Trneny, M.; Offner, F.; Caballero, D.; Joao, C.; Witzens-Harig, M.; Hess, G.; Bence-Bruckler, I.; Cho, S-G; Thieblemont, C.; Zhou, W.; Henninger, T.; Goldberg, J.; Vermeulen, J. und Dreyling, M.
(2018):
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study.
In: Leukemia, Bd. 32, Nr. 8: S. 1799-1803
Jerkeman, M.; Hallek, M.; Dreyling, M.; Thieblemont, C.; Kimby, E. und Staudt, L.
(2017):
Targeting of B-cell receptor signalling in B-cell malignancies.
In: Journal of internal Medicine, Bd. 282, Nr. 5: S. 415-428
Dreyling, M.; Campo, E.; Hermine, O.; Jerkeman, M.; Gouill, S. le; Rule, S.; Shpilberg, O.; Walewski, J. und Ladetto, M.
(2017):
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
In: Annals of Oncology, Bd. 28: S. 62-71
Hoster, Eva; Geisler, C. H.; Doorduijn, J.; van der Holt, B.; Walewski, J.; Bloehdorn, J.; Ribrag, Vincent; Salles, G.; Hallek, M.; Pott, Christiane; Szymczyk, Michal; Kolstad, A.; Laurell, A.; Raty, R.; Jerkeman, M.; Van’t Veer, M.; Kluin-Nelemans, J. C.; Klapper, Wolfram; Unterhalt, Michael; Dreyling, Martin und Hermine, Olivier
(2015):
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
In: Leukemia, Bd. 30, Nr. 6: S. 1428-1430